Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 39

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 39
---
 to attend the Special Meeting or have someone else attend on their behalf, the Beneficial Shareholder may request a legal proxy as set forth in the VIF, which will grant the Beneficial Shareholder or their nominee the right to attend and vote at the Special Meeting.

| Q: | Should I send in my share certificates or other evidence of ownership now? |

| A: | We encourage Registered Shareholders to complete, sign, date and return the enclosed Letter of Transmittal,                                                                                                                                               
 together with their certificate(s) or DRS Advice representing their Common Shares (if applicable) in accordance with the instructions set out in the Letter of Transmittal, as soon as possible, as this will assist in arranging for the prompt exchange 
 of their Common Shares for the Consideration if the Arrangement is completed. If you are a Beneficial Shareholder and your Common Shares are held in “street name” by your broker, bank or other Intermediary, you may receive instructions               
 from your broker, bank or other Intermediary as to what action, if any, you need to take to effect the surrender of your “street name” shares in exchange for the per share Consideration.                                                                |

Where Common Shares are evidenced only by a DRS Advice, there is no requirement to first obtain a share certificate for those Common Shares. Only a properly completed and duly executed Letter of Transmittal and the applicable certificate(s) or DRS Advice(s) are required to be delivered to the Depositary in order to surrender those Common Shares under the Arrangement. Do not send your Letter of Transmittal and share certificate(s)/DRS Advice(s) to the Company. Please follow the instructions set out in the Letter of Transmittal.

| Q: | When can I expect to receive the Consideration for my Common Shares? |

| A: | Assuming completion of the Arrangement, if you hold your Common Shares through an Intermediary, then you are                                                                                                                                  
 not required to take any action and the Consideration you are entitled to receive will be delivered to your Intermediary though procedures in place for such purposes between CDS and Cede & Co. (as the case may be) or similar entities and 
 such Intermediaries. You should contact your Intermediary if you have any questions regarding this process.                                                                                                                                   |

In the case of Registered Shareholders, as soon as reasonably practical after the Effective Date, which the Parties expect will occur on or about January 30, 2026, assuming due